Ibrutinib, an FDA-approved drug for lymphoma and leukemia, may also help treat and improve poor survival rates for glioblastoma, the most common and deadliest type of brain tumor. It may also be more effective than chemotherapy.
from Medindia Health News https://ift.tt/2J13PUV
No comments:
Post a Comment